🇺🇸 FDA
Patent

US 11701384

Methods and compositions involving interleukin-6 receptor alpha-binding single chain variable fragments

granted A61KA61K38/00A61K40/11

Quick answer

US patent 11701384 (Methods and compositions involving interleukin-6 receptor alpha-binding single chain variable fragments) held by The Regents of the University of California expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jul 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K38/00, A61K40/11, A61K40/31, A61K40/4211